ASP ISOTOPES INC - Form 8-K current report

Form 8-K current report

ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")


FORM 8-K CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, ASPI stockholders are advised
that a Form 8-K has been filed with the U.S. Securities and Exchange Commission ("SEC").

As previously announced, effective January 19, 2026: (i), Paul Mann, the founder and Executive Chairman
of the Company, will resume his role as the Company's Chief Executive Officer and continue as Executive
Chairman, and (ii) Robert Ainscow, who serves as Interim Chief Executive Officer during Mr. Mann's
medical leave of absence, will continue in his position as Chief Operating Officer.

Biographical and other information for Paul Mann is set forth in the Company's definitive proxy statement
filed with the SEC on November 25, 2025 and is incorporated herein by reference. There is no arrangement
or understanding between Mr. Mann and any other person, pursuant to which he was selected as an officer.
The Company has not entered into, amended, or modified any plan, contract, arrangement, grant, or award
in connection with Mr. Mann's re-appointment as Chief Executive Officer.

A copy of the Form 8-K can also be found at: Inline Viewer: ASP Isotopes Inc. 8-K 2025-12-02


The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.


9 December 2025


Sponsor
Valeo Capital Proprietary Limited

Date: 09-12-2025 10:55:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.